Product Description.:
RENAGEL 400
tablet , film-coated , white , oval oblong
Black ink
Renagel? (sevelamer hydrochloride)
Renagel controls serum phosphorus levels without the concern of calcium or metal accumulation.
New KDOQI guidelines recommend Sevelamer as a first-line option for the reduction of phosphorus in Chronic Kidney Disease (CKD) patients on hemodialysis.
Renagel? (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
* is contraindicated in patients with hypophosphatemia or bowel obstruction.
* should be exercised in patients with dysphagia, swallowing disorders, severe gastrointestinal (GI) motility disorders including severe constipation or major GI tract surgery.
* adverse events reported with Renagel include vomiting, nausea, diarrhea, dyspepsia, abdominal pain, and constipation.
* events reported include pruritus, rash, fecal impaction, and intestinal obstruction.
* interactions may occur with some medications and should be taken into consideration when instructing patients how to take Renagel.
* should be informed to take Renagel with meals and to adhere to their prescribed diets.
